Craft
Enara Bio

Enara Bio

Total Funding

$17.5 M

Enara Bio Summary

Company summary

Overview
Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer. It develops EDAPT, a differentiated technology platform designed to explore the new and expanding Dark Antigen repertoire and to identify and assess its tumor specificity and immunogenic potential to combat cancers.
Type
Private
Founded
2016
HQ
Oxford, GB | view all locations
Website
https://enarabio.com/
Cybersecurity rating
Sectors

Key people

  • Kevin Pojasek

    Kevin Pojasek, President and Chief Executive Officer, Director

  • Ray Jupp

    Ray Jupp, Chief Scientific Officer

  • Jonathon Dines

    Jonathon Dines, Finance Director

  • Mark Creighton-Gutteridge

    Mark Creighton-Gutteridge, Vice President, Head of Research

    LocationsView all

    4 locations detected

    • Oxford, England HQ

      United Kingdom

      Magdalen Centre, Robert Robinson Ave, Littlemore

    • London, England

      United Kingdom

      55-56 Russell Square, Holborn

    • London, England

      United Kingdom

      71 Kingsway, Holborn

    • Oxford, England

      United Kingdom

      Headington

    Footer menu